Octreotide for advanced hepatocellular cancer revisited: Final data of a meta-analysis approach based on single patient data

15508 Background: Octreotide as systemic treatment for locally advanced or metastatic hepatocellular cancer (HCC) has revealed conflictive results. Methods: To estimate a potential benefit of octre...